NCT06560073View on ClinicalTrials.gov

Intravenous Tranexamic Acid in Diabetic Macular TRD Surgeries

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

October 31, 2022

Conditions
Diabetic RetinopathyMacular Traction Retinal Detachment
Trial Locations (1)

678557

Ahaliafoundation Eye Hospital, Palakkad

All Listed Sponsors
lead

Ahalia Foundation Eye Hospital

OTHER

NCT06560073 - Intravenous Tranexamic Acid in Diabetic Macular TRD Surgeries | Biotech Hunter | Biotech Hunter